Thermo Fisher Scientific
TMO
1,351 hedge funds and large institutions have $86.9B invested in Thermo Fisher Scientific in 2018 Q3 according to their latest regulatory filings, with 108 funds opening new positions, 444 increasing their positions, 567 reducing their positions, and 65 closing their positions.
66% more first-time investments, than exits
New positions opened: 108 | Existing positions closed: 65
19% more capital invested
Capital invested by funds: $72.9B → $86.9B (+$14B)
19% more funds holding in top 10
Funds holding in top 10: 99 → 118 (+19)
2% more funds holding
Funds holding: 1,323 → 1,351 (+28)
0.75% more ownership
Funds ownership: 87.56% → 88.3% (+0.75%)
9% less call options, than puts
Call options by funds: $282M | Put options by funds: $310M
22% less repeat investments, than reductions
Existing positions increased: 444 | Existing positions reduced: 567
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$819M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$588M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$571M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$234M |
| 5 |
FAM
Fred Alger Management
New York
|
+$213M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$626M |
| 2 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$393M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$349M |
| 4 |
FPA
First Pacific Advisors
El Segundo,
California
|
-$242M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$139M |
TMO Hedge Fund Activity: Q3 2018 in Review
1,351 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2018, worth a combined $86.9B — up 19% from $72.9B a quarter earlier.
Buyers outnumbered sellers: 108 funds opened new TMO positions and 65 closed out — a net gain of 43 holders — while 444 added to existing stakes and 567 trimmed.
The largest buyer was Capital International Investors, opening a new position worth an estimated $819M. The largest seller was Capital Research Global Investors, cutting an estimated $626M.
- 1,351 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2018, up from 1,323 in Q2 2018.
- Funds reported $86.9B of Thermo Fisher Scientific stock for Q3 2018, up 19% quarter-over-quarter.
- 108 funds opened new Thermo Fisher Scientific positions in Q3 2018 and 65 closed out, a net change of +43 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2018 was Capital International Investors, an estimated $819M added.
- The largest Thermo Fisher Scientific seller in Q3 2018 was Capital Research Global Investors, an estimated $626M sold.
Based on aggregated 13F filings for Q3 2018.